More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$130.88B
EPS
4.07
P/E ratio
21.7
Price to sales
3.01
Dividend yield
2.815%
Beta
0.568961
Previous close
$102.88
Today's open
$102.75
Day's range
$102.12 - $103.84
52 week range
$73.31 - $106.33
show more
CEO
Geoffrey S. Martha
Employees
95000
Headquarters
Galway,
Exchange
New York Stock Exchange
Shares outstanding
1.28B
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Should You Continue to Hold Medtronic Stock in Your Portfolio?
MDT's growth prospects gain momentum from Hugo adoption, international expansion and Neuroscience advances, despite margin and currency headwinds.
Zacks Investment Research • 9 hours ago

4 High-Yield Healthcare Stocks Retirees Should Buy for December Income
Healthcare demand holds up when the economy slows, which makes the sector a natural place for retirees to look for income heading into the new year. The quality of that income varies widely, though.
24/7 Wall Street • 9 hours ago

This Medtronic Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Benzinga • Nov 17, 2026

MDT Q2 Earnings Preview: Will Cardiovascular Performance Lift Results?
Medtronic's Q2 results may benefit from strong Cardiovascular performance, led by cardiac ablation momentum, while Neuroscience and Diabetes add growth.
Zacks Investment Research • Nov 17, 2026

Medtronic announces FDA clearance of general surgery procedures for the Hugo™ robotic-assisted surgery (RAS) system
An expanded U.S. 510(k) extends the Hugo™ RAS system's reach into one of the fastest-growing areas of U.S. robotic surgery. GALWAY, Ireland, Nov. 17, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) has cleared the Hugo™ robotic-assisted surgery (RAS) system for use in general surgery procedures.
PRNewsWire • Nov 17, 2026

Is Medtronic (MDT) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Zacks Investment Research • Nov 17, 2026

Medtronic to acquire Contego Medical, expanding access to next-generation carotid therapies
GALWAY, Ireland, Nov. 16, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), the global leader in healthcare technology, today announced its intent to acquire Contego Medical, a privately held medical device company focused on innovative solutions for carotid artery disease and peripheral thrombectomy. The acquisition will build on the company's successful, exclusive U.S. distribution agreement with Contego, first announced in January 2025, and advances the Medtronic strategy of pursuing targeted investments that strengthen the company's core franchises.
PRNewsWire • Nov 16, 2026

14 dividend stocks selected for long-term growth
There are a variety of ways to select dividend stocks. John Buckingham, a veteran value-oriented stock picker, believes the best approach is to focus on a stock's total return potential, which means emphasizing long-term growth first, and income second.
Market Watch • Nov 13, 2026

Medtronic Kept Growing When All Eyes Were On AI, Time To Give This Growth Justice
Medtronic expands its heart-rhythm business with Affera and PulseSelect, driving material revenue growth and recurring procedure sales opportunities. CMS coverage for Symplicity Spyral renal denervation removes a key commercial barrier, enabling access to over 18 million U.S. target patients with hypertension. The Hugo robotic surgery platform gains initial U.S. clearance for urologic procedures, with future growth tied to instrument expansion and procedure approvals.
Seeking Alpha • Nov 12, 2026

Medtronic (MDT) Dips More Than Broader Market: What You Should Know
The latest trading day saw Medtronic (MDT) settling at $101.6, representing a -1.16% change from its previous close.
Zacks Investment Research • Nov 10, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Medtronic plc. commission-free¹. Build wealth for the long term using automated trading and transfers.